JW Pharmaceutical Showcases Promising New Hair Loss Treatment at Dermatology Conference
JW Pharmaceutical announced on May 20 that it presented the superiority of JW0061, a Wnt-targeted hair loss treatment, in folliculogenesis and hair growth compared to existing hair loss treatments at the Society for Investigative Dermatology in Dallas, …